NCT05419531Completed
The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50
Measuring the Incidence of Colorectal Cancer in Young Endurance Athletes
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to determine the frequency of colorectal cancer in male and female endurance athletes between the ages of 35 and 50.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 94 (actual)
- First submitted
- 10 Jun 2022
- Start date
- 18 Oct 2022
- Primary completion date
- 22 Oct 2025
- Lead sponsor
- Inova Health Care Services
- Diseases
- Colorectal cancer
- NCT number
- NCT05419531
What you commit to
- Study type: Observational
- Participants enrolled: 94
- From 18 Oct 2022 to the primary completion date, 22 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant illness that would prevent adequate patient assessment or in the investigators' opinion pose an added risk for study participants.
Other illness
- Known or suspected history of inflammatory bowel disease, familial adenomatous polyposis (FAP), or Lynch Syndrome
- Persons with decisional incapacity/cognitive impairment
- Any history or evidence of severe illness or any other condition that would make the patient, in the opinion of the investigator unsuitable for the study
Other
- Anticipated poor compliance
- Prisoners or subjects who are involuntarily incarcerated
- Subject is involved with a worker's compensation, personal injury, or other legal matters related to their health
- Subject is enrolled in a separate interventional clinical trial
Who the study is looking for
- Adult males and females 35-50 years of age
- Male and female self-reported endurance athletes, defined by at least one of the following:
- Run at least two races of 50 miles or more
- Run 5 races of 26.2 miles or more
- Ability to complete testing in the protocol and make study visits
- Able and willing to consent to protocol
Age in the registry: 35 years to 50 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inova Schar Cancer Institute Coordinator of this site? Confirm its status | Fairfax | United States | Unknown status |
Related publications
- Advanced adenomas among young endurance runners: A prospective hypothesis-generating prevalence study.Cancer Epidemiol · 2026 · PMID 42066739
This page is information, not medical advice. Discuss any trial with your doctor.